Hypera SA
BOVESPA:HYPE3

Watchlist Manager
Hypera SA Logo
Hypera SA
BOVESPA:HYPE3
Watchlist
Price: 23.73 BRL 1.71% Market Closed
Market Cap: 15B BRL

Profitability Summary

Hypera SA's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Hypera SA

Margins Comparison
Hypera SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
BR
Hypera SA
BOVESPA:HYPE3
15B BRL
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
984.9B USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
273.3B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
207.6B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
218.5B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.2B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.1B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Hypera SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
BR
Hypera SA
BOVESPA:HYPE3
15B BRL
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
984.9B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
273.3B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
207.6B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
218.5B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.2B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.1B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Hypera SA

Last Value
3-Years Average
FCF Margin
Conversion Rate